These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 35078505

  • 1. The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma.
    Ma L, Xue X, Zhang X, Yu K, Xu X, Tian X, Miao Y, Meng F, Liu X, Guo S, Qiu S, Wang Y, Cui J, Guo W, Li Y, Xia J, Yu Y, Wang J.
    J Exp Clin Cancer Res; 2022 Jan 25; 41(1):36. PubMed ID: 35078505
    [Abstract] [Full Text] [Related]

  • 2. N6-methyladenosine-modified SRPK1 promotes aerobic glycolysis of lung adenocarcinoma via PKM splicing.
    Wang A, Zeng Y, Zhang W, Zhao J, Gao L, Li J, Zhu J, Liu Z, Huang JA.
    Cell Mol Biol Lett; 2024 Aug 02; 29(1):106. PubMed ID: 39095708
    [Abstract] [Full Text] [Related]

  • 3. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
    Zhu S, Chen W, Wang J, Qi L, Pan H, Feng Z, Tian D.
    Theranostics; 2021 Aug 02; 11(7):3359-3375. PubMed ID: 33537092
    [Abstract] [Full Text] [Related]

  • 4. The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function.
    Ma L, Chen T, Zhang X, Miao Y, Tian X, Yu K, Xu X, Niu Y, Guo S, Zhang C, Qiu S, Qiao Y, Fang W, Du L, Yu Y, Wang J.
    Redox Biol; 2021 Jan 02; 38():101801. PubMed ID: 33232910
    [Abstract] [Full Text] [Related]

  • 5. METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma.
    Wu Y, Chang N, Zhang Y, Zhang X, Xu L, Che Y, Qiao T, Wu B, Zhou Y, Jiang J, Xiong J, Zhang J, Zhang J.
    J Exp Clin Cancer Res; 2021 Mar 06; 40(1):90. PubMed ID: 33676554
    [Abstract] [Full Text] [Related]

  • 6. CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1.
    Zhou J, Zhang S, Chen Z, He Z, Xu Y, Li Z.
    Cell Death Dis; 2019 Nov 25; 10(12):885. PubMed ID: 31767835
    [Abstract] [Full Text] [Related]

  • 7. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
    Zhang C, Sun Q, Zhang X, Qin N, Pu Z, Gu Y, Yan C, Zhu M, Dai J, Wang C, Li N, Jin G, Ma H, Hu Z, Zhang E, Tan F, Shen H.
    Cancer Commun (Lond); 2022 Jul 25; 42(7):609-626. PubMed ID: 35730068
    [Abstract] [Full Text] [Related]

  • 8. YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.
    Lou X, Ning J, Liu W, Li K, Qian B, Xu D, Wu Y, Zhang D, Cui W.
    Cells; 2021 Jul 02; 10(7):. PubMed ID: 34359836
    [Abstract] [Full Text] [Related]

  • 9. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification.
    Xu Y, Lv D, Yan C, Su H, Zhang X, Shi Y, Ying K.
    Cancer Cell Int; 2022 Jan 07; 22(1):11. PubMed ID: 34996469
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic, progressive and prognostic performance of m6A methylation RNA regulators in lung adenocarcinoma.
    Zhuang Z, Chen L, Mao Y, Zheng Q, Li H, Huang Y, Hu Z, Jin Y.
    Int J Biol Sci; 2020 Jan 07; 16(11):1785-1797. PubMed ID: 32398949
    [Abstract] [Full Text] [Related]

  • 11. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
    Zhang Y, Liu X, Liu L, Li J, Hu Q, Sun R.
    Med Sci Monit; 2020 Feb 22; 26():e919644. PubMed ID: 32086933
    [Abstract] [Full Text] [Related]

  • 12. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
    Shi K, Sa R, Dou L, Wu Y, Dong Z, Fu X, Yu H.
    Clin Epigenetics; 2023 Sep 23; 15(1):153. PubMed ID: 37742030
    [Abstract] [Full Text] [Related]

  • 13. NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m5C-dependent manner.
    Du X, Cheng C, Yang Y, Fan B, Wang P, Xia H, Ni X, Liu Q, Lu L, Wei L.
    Mol Carcinog; 2024 May 23; 63(5):962-976. PubMed ID: 38411298
    [Abstract] [Full Text] [Related]

  • 14. ALKBH5 promotes the development of lung adenocarcinoma by regulating the polarization of M2 macrophages through CDCA4.
    Tan J, Chen F, Wang J, Li J, Ouyang B, Li X, Li Y, Zhang W, Jiang Y.
    Gene; 2024 Feb 15; 895():147975. PubMed ID: 37949419
    [Abstract] [Full Text] [Related]

  • 15. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
    Liu XS, Zhou LM, Yuan LL, Gao Y, Kui XY, Liu XY, Pei ZJ.
    Front Immunol; 2021 Feb 15; 12():724741. PubMed ID: 34335635
    [Abstract] [Full Text] [Related]

  • 16. N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer.
    Jin H, Ying X, Que B, Wang X, Chao Y, Zhang H, Yuan Z, Qi D, Lin S, Min W, Yang M, Ji W.
    EBioMedicine; 2019 Sep 15; 47():195-207. PubMed ID: 31409574
    [Abstract] [Full Text] [Related]

  • 17. N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
    Teng Y, Zhao X, Xi Y, Fu N.
    Cancer Biol Ther; 2023 Dec 31; 24(1):2249173. PubMed ID: 37700507
    [Abstract] [Full Text] [Related]

  • 18. Deciphering N6-Methyladenosine-Related Genes Signature to Predict Survival in Lung Adenocarcinoma.
    Zhu J, Wang M, Hu D.
    Biomed Res Int; 2020 Dec 31; 2020():2514230. PubMed ID: 32258108
    [Abstract] [Full Text] [Related]

  • 19. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination.
    Shen C, Liu J, Xie F, Yu Y, Ma X, Hu D, Liu C, Wang Y.
    Cancer Lett; 2024 Jul 28; 595():217002. PubMed ID: 38823761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.